Clinical Trial Update: CS-1008 With Carboplatin/Paclitaxel in Chemotherapy naïve Subjects With Metastatic or Unresectable Non-small Cell Lung Cancer (NSCLC) [Phase 2]

View source ↗

Summary

This clinical trial update reports the completed Phase 2 study of CS-1008 with carboplatin/paclitaxel in chemotherapy-naïve patients with metastatic or unresect…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• CS-1008
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: COMPLETED